Methadone and Alcoholism: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge

Methadone And Alcoholism in the News

Methadone And Alcoholism: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge
Lightlake recently acquired patents that will allow it to widen its product pipeline to address patients with addictions to opioid painkillers, methadone, cocaine and amphetamine. The Company anticipates launching a development program for each of
Read more on MarketWatch (press release)

More Methadone And Alcoholism Information…